Nextwell Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 3 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 1494.79%
- Profit Growth 916.97%
- Ebitda -1.57%
- Net Worth 207.37%
- Total Assets 761.85%
About Nextwell Pharmaceutical
Nextwell Pharmaceutical Private Limited (NPPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 24 November 2021 (Three years and two months 28 days old ). Its registered office is in Surat, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Milan Ghevariya and Hardikbhai Ghevariya serve as directors at the Company.
Company Details
- Location
Surat, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24110GJ2021PTC127493
- Company No.
127493
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Nov 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
What products or services does Nextwell Pharmaceutical Private Limited offer?
Nextwell Pharmaceutical Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Anti Inflammatory and Immunosuppressant API, Cardiovascular Drugs & Medication, Blood Pressure Medicine, TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Hand Sanitizers & Personal Hygiene, Hair Shampoo.
Who are the key members and board of directors at Nextwell Pharmaceutical?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Milan Ghevariya  | Director | 24-Nov-2021 | Current |
| Hardikbhai Ghevariya | Director | 24-Nov-2021 | Current |
Financial Performance of Nextwell Pharmaceutical.
Nextwell Pharmaceutical Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 1494.79% increase. The company also saw a substantial improvement in profitability, with a 916.97% increase in profit. The company's net worth Soared by an impressive increase of 207.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nextwell Pharmaceutical?
Unlock access to Nextwell Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nextwell Pharmaceutical?
Nextwell Pharmaceutical has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nextwell Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nextwell Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.